spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  neurodegenerative 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 10 Apr 2025
BrainStorm Cell Therapeutics Submits IND Amendment to FDA, Paving the Way for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 4 Apr 2025
Neurocrine Biosciences Appoints Dr. Sanjay Keswani as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Jan 2025
Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 19 Dec 2024
Astellas and Sangamo Therapeutics Announce Capsid License Agreement to Deliver Genomic Medicines for Neurological Diseases
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 6 Aug 2024
NeuroTherapia Raises $12.3M in the First Close of its Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Jul 2024
ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 20 Jun 2024
BrainStorm Cell Therapeutics Announces Appointment of Haro Hartounian Ph.D. as Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Jun 2024
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 15 Apr 2024
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 23 Feb 2024
BrainStorm Cell Therapeutics Submits Special Protocol Assessment (SPA) Request to FDA for Phase 3b Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 5 Jan 2024
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
Regenerative Medicine Neurosurgery Oncology FDA
 HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Oct 2023
BrainStorm Cell Therapeutics to Meet with US FDA to Discuss Development Plan for NurOwn as a Treatment of ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Oct 2023
Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Diagnostics Neurology Product Launch
 HSMN NewsFeed - 12 Jul 2023
BrainStorm Cell Therapeutics Appoints Bob Dagher, M.D., as Executive Vice President and Chief Development Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 27 Mar 2023
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn(R) for the Treatment of ALS
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 9 Mar 2023
QurAlis Closes $88 Million Series B Financing to Advance Precision Medicines for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 7 Mar 2023
Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 23 Feb 2023
AbbVie and Capsida Biotherapeutics Expand Strategic Collaboration to Develop Targeted Genetic Medicines for Eye Diseases with High Unmet Need
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 Feb 2023
KeifeRx Appoints Garrett Vygantas, MD, MBA, to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jan 2023
Halia Therapeutics Appoints Former Amgen Executive, Margit M. Janát-Amsbury, MD, Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 2 Dec 2022
SciNeuro Pharmaceuticals Announces the Appointment of Guojun Bu, Ph.D., as Chief Scientific Officer, and Provides Update on Pipeline of Novel CNS Therapeutics
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 10 Nov 2022
BrainStorm Cell Therapeutics Receives Refusal to File Letter from FDA for its New Biologics License Application for NurOwn for the treatment of ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 15 Sep 2022
BrainStorm Cell Therapeutics Announces Peer Reviewed Publication of Results from the NurOwn(R) Phase 2 Progressive MS Trial in Multiple Sclerosis Journal
Regenerative Medicine Neurology
 HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2022
ProJenX Names Life Sciences Industry Veteran Stan E. Abel as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Apr 2022
Lantern Pharma's Board of Directors Names Maria Maccecchini, Ph.D. as a Director Nominee to Lantern's Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Apr 2022
AbbVie terminates collaboration with BioArctic on alpha-synuclein portfolio
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2022
Neuron23 Appoints Sam Jackson, M.D., MBA, as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Mar 2022
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 29 Mar 2022
Stem cell biotech Neuroplast enrolls first patient in Phase II clinical trial of transformative Neuro-Cells(R) treatment for Traumatic Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Mar 2022
NeuroSense Therapeutics Receives FDA Clearance of IND for PrimeC for the Treatment of ALS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 25 Feb 2022
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Feb 2022
Lilly Announces the Institute for Genetic Medicine and $700 Million investment in Boston Seaport Site
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2022
Arkuda Therapeutics Raises $64 Million Series B Financing to Advance Pipeline of Programs Targeting Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 11 Jan 2022
Nine Square Therapeutics Appoints Robert Paul as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 Jan 2022
Valo Health Names Dave Morris Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2022
Neuvivo Expands Management Team Adding Gregg Fergus, Former President of Ion Torrent, as Head of Strategy and Business Development and to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 27 Dec 2021
FDA Authorizes Further NurOwn(R) Dosing Under Expanded Access Program
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 8 Dec 2021
KeifeRx Completes $6 Million Series A Financing and Enhances Board of Directors
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 2 Dec 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Nov 2021
BrainStorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Nov 2021
Insightec Announces FDA Approval of Exablate Neuro for the Treatment of Parkinson's Disease
Devices Neurology FDA
 HSMN NewsFeed - 2 Nov 2021
Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense(TM) Data in Rune's Software for Precision Neurology
Devices Neurology
 HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Oct 2021
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Sep 2021
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 9 Sep 2021
Neuroglee Therapeutics Closes Series A Round to Advance Virtual Care and Digital Therapies for Alzheimer's Disease Treatment in the Home
Devices Neurology Venture Capital
 HSMN NewsFeed - 30 Aug 2021
NeuExcell Therapeutics Raises $10+ Million Series Pre-A Round To Continue Its Company Growth
Regenerative Medicine Neurology Venture Capital
 HSMN NewsFeed - 23 Aug 2021
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Aug 2021
Alkermes Receives FDA Fast Track Designation for Nemvaleukin Alfa for the Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Jul 2021
BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 6 Jul 2021
Delix Therapeutics Expands Executive Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Jun 2021
Eisai Inc. Announces the Appointment of Dr. Andree Amelsberg as Vice President, U.S. Medical Affairs, Oncology Business Group
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Jun 2021
Caryn Peterson Joins Aspen Neuroscience Board of Directors
Devices Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 22 Jun 2021
Valeo Pharma Announces Commercial Launch of Enerzair(R) Breezhaler(R) and Atectura(R) Breezhaler(R)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Apr 2021
Capsida Biotherapeutics Debuts with $140 Million of Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Apr 2021
Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 5 Apr 2021
Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Mar 2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Feb 2021
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Jan 2021
Lilly Completes Acquisition of Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2021
Boston Scientific Receives FDA Approval For The Vercise Genus(TM) Deep Brain Stimulation System
Devices Neurology FDA
 HSMN NewsFeed - 18 Jan 2021
Valeo Pharma Announces Major Addition to its Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jan 2021
Cognoptix Appoints New Chief Medical Officer, Dr. Carl Sadowsky, MD, And Chief Financial Officer, Mike Kaswan, MBA, To Management Team
Diagnostics Neurology Personnel
 HSMN NewsFeed - 21 Dec 2020
Servier to Acquire Agios Pharmaceuticals' Oncology Business
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 18 Dec 2020
Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Niemann Pick Disease Types A and B With PLX-300
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Dec 2020
Neuron23(TM) Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 Dec 2020
Lilly Announces Agreement to Acquire Prevail Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 14 Dec 2020
BrainStorm Announces NurOwn(R) Expanded Access Program
Regenerative Medicine Neurology Product Launch
 HSMN NewsFeed - 10 Dec 2020
Cyrano Therapeutics Raises $12.8 Million to Complete Phase 2 Trial of CYR-064 for the Restoration of Chronic Smell and Flavor Loss
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 9 Dec 2020
Valeo Pharma Announces Health Canada Approval for Redesca(TM) and Redesca Hp(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Dec 2020
Neuroglee Therapeutics to Attack Alzheimer's Disease Through Personalized AI-Powered Digital Therapeutics
Devices Neurology Venture Capital
 HSMN NewsFeed - 30 Nov 2020
PTC Therapeutics Announces Initiation of Global Phase 3 Clinical Trial to Evaluate Vatiquinone in Friedreich Ataxia
Biopharmaceuticals
 HSMN NewsFeed - 23 Nov 2020
BrainStorm to present NurOwn(R) Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MND
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Nov 2020
BrainStorm Announces Topline Results from NurOwn(R) Phase 3 ALS Study
Regenerative Medicine Neurology
 HSMN NewsFeed - 12 Nov 2020
Valeo Pharma announces Amikacin approval in CANADA and U.S. launch of Ethacrynate Sodium
Biopharmaceuticals Regulatory Product Launch
 HSMN NewsFeed - 30 Oct 2020
Sana Biotechnology Announces Acquisition of Oscine
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Oct 2020
Enterin Announces Appointment of New CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Sep 2020
NeuroBo Pharmaceuticals Appoints Douglas J. Swirsky to the Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Aug 2020
Clene Nanomedicine Raises Series D Financing of $42.5 Million
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Aug 2020
MedGenome announces Strategic Collaboration in Parkinson's Disease with Denali Therapeutics
Diagnostics Neurology
 HSMN NewsFeed - 24 Aug 2020
Yumanity Therapeutics and Proteostasis Therapeutics Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 29 Jul 2020
Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Jun 2020
BrainStorm Expands Clinical Pipeline to Evaluate NurOwn(R) for the Treatment of Alzheimer's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 27 May 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 23 Apr 2020
SwanBio Therapeutics Announces Series A Expansion to Fund its Lead Program and Grow Pipeline in Gene Therapy for Neurological Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 31 Mar 2020
Relmada Therapeutics Solidifies its R&D Leadership Team with the Appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Mar 2020
Biohaven's Verdiperstat Receives Fast Track Designation For The Treatment Of Multiple System Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Mar 2020
CytRx Corporation Provides Update on Management Change
Biopharmaceuticals Oncology Neurology Personnel
 HSMN NewsFeed - 3 Mar 2020
FDA Grants Rare Pediatric Disease Designation to Stealth BioTherapeutics for Elamipretide for the Treatment of Barth Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2020
Eisai Inc. Expands Leadership Team in the US with the Appointment of Two Key Leaders
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2019
Kodiak Sciences Announces Sale of Future Royalties on KSI-301 for $225 Million to Baker Bros. Advisors
Biopharmaceuticals Ophthalmology Venture Capital
 HSMN NewsFeed - 25 Nov 2019
Alkermes Completes Acquisition of Rodin Therapeutics
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces Clinical Trial Results of REVERSE-SD, a Phase 2b Study of Neflamapimod in Early-stage Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 Nov 2019
Arkuda Therapeutics Closes $44M Series A Financing to Advance Novel Medicines Targeting Progranulin and Lysosomal Biology to Treat Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 30 Oct 2019
Biogen and Alkermes Announce FDA Approval of VUMERITY(TM) (diroximel fumarate) for Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Sep 2019
Biohaven's Verdiperstat, An Oral Myeloperoxidase Inhibitor, Selected For Platform Trial Collaboration At Massachusetts General Hospital's Healey & AMG Center For Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Aug 2019
Priya Chaturvedi, Ph.D., Appointed Vice President of Global Clinical Quality Assurance at Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Aug 2019
Bayer Acquires Bluerock Therapeutics to Build Leading Position in Cell Therapy
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 2 Aug 2019
Axon Neuroscience Appoints Michal Fresser as Group CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jul 2019
Biohaven Enrolls First Patient In Phase 3 Clinical Trial Of Verdiperstat, Oral Myeloperoxidase Inhibitor, For The Treatment Of Multiple System Atrophy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Jul 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jul 2019
Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
Biopharmaceuticals Oncology Neurology
 HSMN NewsFeed - 12 Jul 2019
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Dementia with Lewy Bodies
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Jun 2019
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Jun 2019
Patrick Coyle Appointed Vice President and Chief Financial Officer of Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2019
Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 8 May 2019
Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2019
Athira Pharma Announces Appointment of Dr. Hans J. Moebius as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Apr 2019
EIP Pharma Closes $11.2 Million Financing Round to Advance Development of Neflamapimod in Additional Neurodegenerative Disease Indications
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 4 Apr 2019
Daiichi Sankyo Provides Update on Ongoing FDA Review for Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Mar 2019
Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx(TM) System
Devices Neurology Oncology Drug Delivery FDA
 HSMN NewsFeed - 28 Feb 2019
Daiichi Sankyo Europe and Esperion Announce Validation of the Marketing Authorisation Application (MAA) for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Fixed Dose Combination Tablet
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 22 Feb 2019
Daiichi Sankyo Shifts Several Top Leaders to New Roles for Company's Launch into its Next Growth Phase
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jan 2019
Functional Neuromodulation Announces CEO Leadership Transition
Devices Neurology Personnel
 HSMN NewsFeed - 17 Jan 2019
Asceneuron Appoints Peter Van Vlasselaer as Chairman
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jan 2019
Lisa Genova, Ph.D joins CereVasc Board of Directors
Devices Interventional Neurology Personnel
 HSMN NewsFeed - 14 Jan 2019
Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Low Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Dec 2018
BioArctic Outlicenses its Alpha-synuclein Antibody Portfolio for Parkinson's Disease to AbbVie After Receiving Clearance
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 12 Dec 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Nov 2018
Biohaven Announces FDA Acceptance of 505(b)(2) NDA Filing for BHV-0223, a Novel Sublingual Delivery Form of Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology Drug Delivery FDA
 HSMN NewsFeed - 5 Nov 2018
EMA Validates and Grants Accelerated Assessment of Marketing Authorization Application for Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2018
BioArctic's Partner AbbVie Exercises its Option to License the Alpha-synuclein Antibody Portfolio for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 25 Oct 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Sep 2018
IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2018
REGENXBIO Announces Pipeline Expansion with RGX-181 Gene Therapy for CLN2 Form of Batten Disease
Biopharmaceuticals
 HSMN NewsFeed - 28 Aug 2018
Daiichi Sankyo Presents First Snapshot Analyses from Global ETNA-AF Programme of Oral, Once-daily LIXIANA(R) (edoxaban) in Patients with Nonvalvular Atrial Fibrillation in Routine Clinical Practice
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2018
Dthera Sciences Receives FDA Breakthrough Device Designation For Its Alzheimer's Focused Development-Stage Product "DTHR-ALZ"
Devices Neurology FDA
 HSMN NewsFeed - 23 Aug 2018
E-Scape Bio Appoints Biopharma Industry Veteran Julie Anne Smith As President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Aug 2018
ProMIS Neurosciences Oligomer Selective Antibody Therapeutic for Alzheimer's Disease, PMN310, Shows Potential for Improved Safety Profile in Direct Comparison to Other Amyloid Beta-Directed Antibodies in Clinical Development
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Aug 2018
Eisai And Merck Announce FDA Approval Of LENVIMA(R) (lenvatinib) Capsules For First-Line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Aug 2018
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA(R) (edoxaban)
Biopharmaceuticals
 HSMN NewsFeed - 1 Aug 2018
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Jul 2018
Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 Jul 2018
Biohaven Receives FDA May Proceed Letter And Initiates Phase 2/3 Clinical Trial Of Trigriluzole (BHV-4157) In Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 16 Jul 2018
NeuroTrauma Sciences and Henry Ford Health System Announce Research and License Agreements to Develop Exosome Technology for Neurological Injury
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 6 Jul 2018
BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jun 2018
BrainStorm Strengthens Executive Management Team with the Appointment of Susan Ward, Ph.D. and Joseph Petroziello
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Jun 2018
StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 1 Jun 2018
Fortuna Fix Announces Appointment of Madhavan Balachandran to Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 May 2018
Daiichi Sankyo Announces Single Agent Quizartinib Significantly Prolongs Overall Survival Compared with Chemotherapy in Patients with Relapsed/Refractory AML with FLT3-ITD Mutations (QuANTUM-R Study)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Apr 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Apr 2018
TSO3 Details Results of Prion Inactivation Studies
Devices
 HSMN NewsFeed - 17 Apr 2018
King-Devick technologies receives FDA clearance for K-D Balance(TM) App
Devices FDA
 HSMN NewsFeed - 21 Mar 2018
BrainStorm Appoints Two Leading Thought Leaders in the Fields of Neuroscience and Regenerative Medicine to its Scientific Advisory Board
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 8 Mar 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
Regenerative Medicine Neurology
 HSMN NewsFeed - 13 Feb 2018
Mallinckrodt Completes Acquisition Of Sucampo Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Feb 2018
BrainStorm Cell Therapeutics Appoints Senior Kite Executive, Anthony Polverino, Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 29 Jan 2018
SyntheticMR AB - Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI now FDA Cleared
Devices Radiology Neurology FDA
 HSMN NewsFeed - 24 Jan 2018
Achieve Announces Expansion of Partnership with the University of Bristol for Next Generation Cytisine-Based Therapies to Include Exclusive Rights for Cytisine Development Across Multiple Therapeutic Categories
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Jan 2018
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 11 Jan 2018
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 10 Jan 2018
Morphotek Announces FDA Acceptance Of Investigational New Drug Application For Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Dec 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Dec 2017
Polaryx Therapeutics Receives Orphan Drug Designation From the US FDA for the Treatment of Neuronal Ceroid Lipofuscinoses With PLX-100
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Dec 2017
Merck's Mavenclad (Cladribine Tablets) Approved for Relapsing-Remitting Multiple Sclerosis in Canada
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 1 Dec 2017
Elekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting
Devices Radiology Neurology Product Launch
 HSMN NewsFeed - 27 Nov 2017
Stealth BioTherapeutics Granted Fast Track Designation for the Treatment of Barth Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Nov 2017
BrainStorm Strengthens Executive Team: Appoints Eyal Rubin as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 16 Oct 2017
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 26 Sep 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Sep 2017
Morphotek(R), Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab(R)
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Terminates Development and Commercialization Agreement with Charleston Laboratories Regarding Hydrocodone Products in the U.S., including CL-108
Biopharmaceuticals
 HSMN NewsFeed - 31 Aug 2017
Daiichi Sankyo Announces Positive Top-line Results from Phase 3 Clinical Trial Evaluating Mirogabalin in Diabetic Peripheral Neuropathic Pain
Biopharmaceuticals
 HSMN NewsFeed - 29 Aug 2017
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's DS-8201 for HER2-Positive Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Aug 2017
Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitor for Solid Tumors
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 7 Aug 2017
Alkahest Appoints Helen Jenkins as Chief Operating Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Aug 2017
BrainStorm Supports Commitment to ALS Patient Community with Appointment of a Vice President of Patient Advocacy and Government Affairs
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 2 Aug 2017
Collidion Acquires 80% Stake in Plex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jul 2017
BrainStorm Announces Agreement with University of California Irvine Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Jul 2017
Brainstorm Awarded $16 Million Non-Dilutive Grant from CIRM in Support of Phase 3 Clinical Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 18 Jul 2017
BrainStorm Announces Agreements with Mass. General Hospital and California Pacific Medical Center to Participate in Phase 3 Trial of NurOwn(R) in ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Jul 2017
Enterin Inc. Raises $12.7 Million in Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 17 Jul 2017
CHMP Issues a Positive Opinion for Daiichi Sankyo's Once-Daily LIXIANA(R) (edoxaban) in Patients with Atrial Fibrillation Undergoing Cardioversion
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Biopharmaceutical Neurology Venture Capital
 HSMN NewsFeed - 11 Jul 2017
Nuredis Appoints Julie Anne Smith as Chief Executive Officer to Lead Neurodegenerative Disease Company
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jun 2017
Daiichi Sankyo Announces Top-line Results from Phase 3 Global Clinical Development Program Evaluating Mirogabalin in Pain Syndromes
Biopharmaceuticals
 HSMN NewsFeed - 27 Jun 2017
Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 1 Jun 2017
SPINRAZA(R) (nusinersen) Approved in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 May 2017
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 4 Apr 2017
Teva Announces FDA Approval of AUSTEDO(TM) (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Mar 2017
BrainStorm Strengthens Management Team with Appointment of Ralph Z. Kern, MD, MHSc as Chief Operating Officer and Chief Medical Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 27 Feb 2017
Pharma Two B Ltd. Closes $30 Million Financing Round
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 27 Feb 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 21 Feb 2017
BrainStorm Seeking Approval To Distribute NurOwn(R) in Canada
Regenerative Medicine Neurology Regulatory Distribution
 HSMN NewsFeed - 8 Feb 2017
Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2017
Alkahest Appoints Sam Jackson, M.D., MBA as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 Jan 2017
Eisai Acquires All Global Development And Marketing Rights For Chronic Weight Management Treatment Lorcaserin HCI
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 26 Dec 2016
SPINRAZA(TM) (nusinersen) Approved in U.S. to Treat Broad Range of Patients with Spinal Muscular Atrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Dec 2016
Biogen Names Michel Vounatsos Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2016
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 5 Dec 2016
Mission Therapeutics Appoints Colin Goddard as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Nov 2016
Addex Appoints Biopharmaceutical Industry Veteran, Roger G. Mills, M.D., as Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Nov 2016
Neurotrope Issues Statement On Eli Lilly's Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Nov 2016
Allergan Acquires Chase Pharmaceuticals to Expand CNS R&D Pipeline and Build on Commitment to Alzheimer's Disease
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
Groundbreaking Team At Aquinnah Pharmaceuticals Adds Two New Members To Help Overcome The Challenge Of ALS And Alzheimer's Disease
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 17 Nov 2016
FDA Grants Fast Track Designation for Development of E2609, Eisai's BACE Inhibitor for Early Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 1 Nov 2016
miRagen Therapeutics and Signal Genetics Sign Merger Agreement
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2016
Dr. Daniel Alkon Appointed President of Neurotrope, Inc.
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Jul 2016
ProMIS Neurosciences Announces Appointment of Dr. Johanne Kaplan as Chief Development Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Jul 2016
Amgen And Daiichi Sankyo Announce Agreement To Commercialize Biosimilars In Japan
Biopharmaceuticals
 HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 11 Apr 2016
Beyhan Zaim appointed Vice President Commercial Development & Alzheimer's Disease Global Lead, Neurology Business Group at Eisai Inc.
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Mar 2016
Biogen Appoints Michel Vounatsos Executive Vice President, Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2016
ProMIS Neurosciences announces identification of a second novel therapeutic target for Alzheimer's disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Feb 2016
MISSION Therapeutics Raises £60 million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform
Biopharmaceuticals Oncology Neurology Venture Capital
 HSMN NewsFeed - 1 Feb 2016
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jan 2016
Amylyx Announces Election of Nobel Laureate Walter Gilbert, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Jan 2016
Acorda to Acquire Biotie Therapies
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 12 Jan 2016
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 7 Jan 2016
Exosome Diagnostics Completes $60 Million Series B Financing
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Jan 2016
Alector Announces Closing of Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 5 Jan 2016
Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Dec 2015
NeuroDerm Announces Start of Patient Enrollment in Phase II Trial of ND0612H for Advanced Parkinson’s Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Dec 2015
VistaGen Secures Exclusive Worldwide Commercial Rights to Three Proprietary Stem Cell Technologies from University Health Network
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 18 Dec 2015
Navitor Pharmaceuticals Announces $33 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Dec 2015
BrainStorm Cell Therapeutics Announces Appointment of Dr. Revital Geffen-Aricha as Vice President of Research & Development
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2015
Deep Brain Stimulation of the Fornix (DBSf) Shows Promise as Treatment for Patients with Mild Alzheimer's Disease
Devices Neurology
 HSMN NewsFeed - 9 Oct 2015
Biogen Announces Departure of Tony Kingsley
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2015
VBI Vaccines Promotes Dr. David E. Anderson to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2015
Exosome Diagnostics Raises $17.6 Million in Second Round Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 3 Aug 2015
Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Aug 2015
Intra-Cellular Therapies Expands Leadership Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Aug 2015
BrainStorm Strengthens Executive Team: Announces the Appointment of Yoram Bibring as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 23 Jul 2015
RaNA Therapeutics Secures $55 Million in Oversubscribed Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Jul 2015
GenSight Biologics Closes $36 Million Series B Preferred Stock Financing
Biopharmaceuticals Ophthalmology Venture Captial
 HSMN NewsFeed - 15 Jul 2015
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 May 2015
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 14 May 2015
Denali Therapeutics Launches with Initial Investment to Discover and Develop Treatments for Neurodegenerative Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Mar 2015
StemCells, Inc. Appoints Ian Massey as President and Chief Operating Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 23 Mar 2015
Biogen Idec Becomes Biogen
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2015
Coronado Biosciences Announces Exclusive Licensing Agreement With NeuPharma to Develop and Commercialize Novel Covalent 3rd Generation EGFR Inhibitors
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Jan 2015
NeuroPhage Expands Series D Financing To $27 Million
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 24 Dec 2014
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 4 Nov 2014
NeuroPhage Appoints Industry Veteran Franz Hefti, PhD, President/COO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2014
AbVitro Inc. Appoints Jeffrey M. Ostrove, Ph.D. as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2014
Raptor Pharmaceutical Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2014
Health Canada Approves Eloctate(TM), the First Therapy to Extend the Interval Between Prophylactic Infusions in Hemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Jul 2014
Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Jun 2014
Proteostasis Therapeutics Appoints Meenu Chhabra as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2014
Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jun 2014
Complexa, Inc. Completes $13 Million Series B Financing to Further Advance Clinical Development of CXA-10
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 May 2014
GE Healthcare and CorTechs Labs Inc. Announce Strategic Agreement to Co-Market NeuroQuant(R), Comprehensive Solutions for Quantifying Brain Volume Loss
Devices Neurology Radiology Distribution
 HSMN NewsFeed - 12 May 2014
Lysosomal Therapeutics Inc. Receives $4.8 Million in Seed Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 29 Apr 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2014
Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2014
AtheroNova Appoints Dr. Randolph M. Johnson as Chief Operating Officer
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 2 Apr 2014
EnVivo Pharmaceuticals, Inc. Becomes FORUM Pharmaceuticals Inc.
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 Apr 2014
Mahendra Rao, MD, PhD Joins Q Therapeutics as Chief Strategy Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2014
NeuroPhage, Inc. Raises $17 Million In Series D Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 25 Mar 2014
BrainStorm and Massachusetts General Hospital Sign Definitive Agreement for ALS Clinical Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 24 Mar 2014
Health Canada Approves Biogen Idec's Long-Acting ALPROLIX(TM) Therapy for Hemophilia B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2014
Exosome Diagnostics Raises $27 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 10 Mar 2014
Intra-Cellular Therapies Announces the Appointment of Juan Sanchez, M.D., as Vice President of Corporate Communications and Investor Relations
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 13 Feb 2014
MYOS Corporation Announces Appointment of Robert C. Ashton, Jr., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2014
Biogen Idec and UCB Enter Agreements to Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jan 2014
Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
Biopharmaceuticals
 HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 17 Dec 2013
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF Biosimilar Product Candidates in Europe
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 26 Nov 2013
Guri Stark Joins CorTechs Labs as CEO
Devices Radiology Personnel
 HSMN NewsFeed - 18 Oct 2013
Celladon Corporation Appoints Michael Narachi as Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2013
Nuron Biotech Announces Appointment of New Management Team Members and Provides an Update on Commercial Vaccine Meningitec(TM)
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 4 Oct 2013
New TECFIDERA(R) (Dimethyl Fumarate) Data Show Sustained Efficacy and Long-Term Safety in a Broad Range of Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Sep 2013
FDA Grants Orphan Drug Designation to Omeros' OMS824 for Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Diagnostics Personnel
 HSMN NewsFeed - 11 Sep 2013
Civitas Therapeutics Secures $38 Million in Financing
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 10 Sep 2013
Amicus Therapeutics Enters Collaboration With Biogen Idec for Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 9 Sep 2013
Biogen Idec and Isis Pharmaceuticals Announce Strategic Collaboration to Advance Treatment of Neurological Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 4 Sep 2013
$30 Million Secured in iPierian Financing and Series A Financing for Launch of Spin-out, True North Therapeutics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2013
EMD Serono President and Head of US Operations James Hoyes Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jun 2013
Boston Scientific Vercise(TM) DBS System demonstrates Improvement In Motor Function For Patients With Parkinson's Disease
Devices Neurosurgery
 HSMN NewsFeed - 23 May 2013
Biogen Idec Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 May 2013
Biogen Idec Submits Application to FDA for Approval of PLEGRIDY(TM) (Peginterferon Beta-1a) in Multiple Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 May 2013
NeuroPhage, Inc. Raises $6.4 Million In Additional Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Feb 2013
Lpath Promotes Leigh Hsu, Ph.D., to Vice President of Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 3 Jan 2013
Biogen Idec Reports Top-Line Results from Phase 3 Trial Investigating Dexpramipexole in People with Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 26 Dec 2012
Amarantus BioScience Acquires Neurodegenerative Diagnostic Intellectual Property Portfolio from Power3 Medical Products
Biopharmaceuticals Diagnostics Neurology Acquisitions
 HSMN NewsFeed - 10 Dec 2012
Nuron Biotech Acquires Commercial, Preventive Vaccine Meningitec(TM) from Pfizer
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Nov 2012
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
Regenerative Medicine Neurology
 HSMN NewsFeed - 12 Oct 2012
New Data from Phase 3 Studies Provide Additional Evidence Supporting Treatment Effect for Oral BG-12 (Dimethyl Fumarate) in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Aug 2012
Neuren Appoints Joseph Horrigan, M.D., as VP of Clinical Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2012
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2012
EMD Serono, Inc. Strengthens Leadership Teams with New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2012
Eisai Gains Positive CHMP Opinion for Fycompa(R) (perampanel) First in a New Class of Treatment for Partial Onset Epilepsy
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 22 May 2012
EnVivo Pharmaceuticals Appoints Alfred Sandrock, M.D., Ph.D., to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Apr 2012
Oligomerix, Inc. Completes $2 Million Series A Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 28 Feb 2012
FDA Approves AVONEX(R) PEN(TM) and Dose Titration Regimen
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 15 Feb 2012
FDA Accepts Pfizer’s New Drug Application for Tafamidis Meglumine, a Novel, Investigational Treatment for Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Feb 2012
Biogen Idec to Acquire Stromedix
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 3 Feb 2012
Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jan 2012
Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2012
Accera, Inc. Elects Industry Veteran Holger Kunze as CEO and as a Member of the Company's Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 Nov 2011
Pfizer’s Vyndaqel(R) (tafamidis) First Therapy Approved in the European Union for the Rare and Fatal Neurodegenerative Disease Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2011
iPierian Appoints Nancy Stagliano as CEO; Peter Van Vlasselaer, Interim CEO, Becomes Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2011
Genzyme and Isis Announce Submission of European Marketing Authorization Application for Mipomersen (Kynamro(R))
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jun 2011
Repligen Receives U.S. Fast Track Designation and European Orphan Medicinal Product Recommendation for RG3039 for Spinal Muscular Atrophy
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2011
AVI BioPharma Names Ed Kaye, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2011
EMD Serono President and CEO Fereydoun Firouz Resigns
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Appoints Kathlene L. Powell Vice President, Quality Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2011
NeuroPhage Pharmaceuticals Closes $12.4M Series B Round
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 23 Feb 2011
Allon Appoints Dr. Michael Gold Chief Medical Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Feb 2011
sanofi-aventis to Acquire Genzyme for $74.00 in Cash Per Share Plus Contingent Value Right
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Jan 2011
Genzyme Will Allow sanofi-aventis to Conduct Due Diligence
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Jan 2011
Genzyme Statement on Discussions with sanofi-aventis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jan 2011
Raptor Pharmaceutical Hires Patrick Reichenberger to Lead Commercial Development of DR Cysteamine for Nephropathic Cystinosis
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2011
Boston Scientific Acquires Intelect Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 16 Dec 2010
GlaxoSmithKline and Impax Pharmaceuticals Enter Global Agreement to Develop and Commercialize a late stage compound for Parkinson’s Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Dec 2010
StemCells, Inc. Receives Authorization to Conduct World's First Neural Stem Cell Trial in Spinal Cord Injury
Regenerative Medicine Neurology
 HSMN NewsFeed - 6 Dec 2010
NeuroVive Obtains U.S. Orphan Drug Designation for Traumatic Brain Injury
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Nov 2010
FDA Approves EGRIFTA(TM) (Tesamorelin for Injection): The First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-Infected Patients With Lipodystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Nov 2010
Ceregene Raises $11.5 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Nov 2010
Boston Scientific Begins Patient Enrollment in Clinical Trial Assessing Deep Brain Stimulation for Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 8 Nov 2010
Lilly to Acquire Avid Radiopharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Oct 2010
Genzyme Announces Results of Phase 3 Trial of Clolar in Adult AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2010
Synosia Therapeutics Raises $30M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Oct 2010
Cortex Obtains Exclusive Worldwide Rights for the Combination of AMPAKINE(R) and mGluR5 Compounds for the Treatment of Fragile X
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 4 Oct 2010
Genzyme Board Urges Shareholders to Take No Action On sanofi-aventis’ Unsolicited Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2010
iPierian Announces Second Close of $28 Million Series B Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2010
Genzyme Confirms Receipt of Unsolicited Proposal
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Aug 2010
Alectos Therapeutics Announces Collaboration With Merck to Develop Drugs for Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 Aug 2010
Signum Biosciences Names Braham Shroot as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Jul 2010
Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept(R) (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 30 Jun 2010
Raptor Pharmaceutical Announces License Agreement for Convivia(TM)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 22 Jun 2010
Ipsen: Encouraging results of GuidAge(R), large scale European trial conducted in the prevention of Alzheimer's Dementia
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jun 2010
Elekta Introduces Next Generation MEG System for Monitoring the Brain in Action
Devices Neurology
 HSMN NewsFeed - 7 Jun 2010
Elekta Introduces Next Generation MEG System for Monitoring the Brain in Action
Devices Neurology Monitoring
 HSMN NewsFeed - 25 May 2010
Genzyme Receives FDA Approval for Lumizyme for Pompe Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 May 2010
Repligen Receives Orphan Drug Designation from the FDA for RG2833 for Friedreich's Ataxia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 May 2010
BrainStorm Announces Significant Milestones Achieved and 2009 Review
Regenerative Medicine Neurology
 HSMN NewsFeed - 5 May 2010
FoldRx Pharmaceuticals Appoints Dr. Georges Gemayel as Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Apr 2010
Satori Pharmaceuticals Adds Key Senior Members to its Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 14 Apr 2010
QRxPharma Successfully Completes Pivotal Phase 3 Combination Rule Study for MoxDuo(R)IR in Patients with Post-Surgical Pain
Biopharmaceuticals Surgery
 HSMN NewsFeed - 6 Apr 2010
Allon Therapeutics Announces Davunetide Receives FDA Fast Track Status for Treatment of Progressive Supranuclear Palsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 30 Mar 2010
Genzyme Creates Chief Operating Officer Position
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Mar 2010
Merck Serono: Erbitux Granted Extended Use in Japan for 1st-Line Treatment of mCRC Patients with KRAS Wild-Type Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 25 Mar 2010
Proteostasis Therapeutics Announces Additions of Key Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2010
St. Jude Medical Receives Australian TGA Regulatory and Reimbursement Approval for World's Smallest Rechargeable Deep Brain Stimulator for Parkinson's Disease
Devices Regulatory Neurology
 HSMN NewsFeed - 12 Mar 2010
Genetix Pharmaceuticals Secures $35M in Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Mar 2010
Cytokinetics Announces Orphan Drug Designation Granted to CK-2017357 for the Treatment of Amyotrophic Lateral Sclerosis
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 2 Mar 2010
International Stem Cell Corporation Parthenogenetic Stem Cell Line Shown to Carry the Most Common Immune Genes Matched to the U.S. Population Retains Stem Cell Characteristics over Two Years in Culture, Which is Necessary for Therapeutic Value
Regenerative Medicine
 HSMN NewsFeed - 23 Feb 2010
iPierian Appoints Dr. Michael Venuti as President and Chief Scientific Officer
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Feb 2010
Medtronic: Advanced Deep Brain Stimulation Therapy Now Available in Canada
Devices Neurology Neurosurgery Regulatory
 HSMN NewsFeed - 8 Feb 2010
KineMed Broadens Collaboration with Bristol-Myers Squibb
Biopharmaceuticals Personalized Medicine Neurology
 HSMN NewsFeed - 8 Feb 2010
Neuraltus Pharmaceuticals Names Andrew Gengos President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2010
Scott Canute Joins Genzyme to Head Manufacturing and Corporate Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2010
Neuralstem Announces First Patient Treated in ALS Stem Cell Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 21 Jan 2010
Two-Year Results From CLARITY Study with Cladribine Tablets in Multiple Sclerosis Published in The New England Journal of Medicine
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jan 2010
Acetylon Pharmaceuticals Tops Up Series A Financing with $2 Million Note And Appoints Simon Jones VP Biology and Preclinical Development and John van Duzer VP Chemistry and Manufacturing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 8 Jan 2010
Industry Veteran Ron Branning Joins Genzyme to Lead Global Product Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals
 HSMN NewsFeed - 21 Dec 2009
California Stem Cell, Inc Closes Series B Financing Round
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 18 Nov 2009
StemCells, Inc. Provides Update on NCL Program Meeting with FDA
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 7 Oct 2009
Epizyme Closes $32 Million Series B Financing, Led by New Investor Bay City Capital
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Oct 2009
Amber Salzman Named President and CEO of Cardiokine
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2009
Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Sep 2009
Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 10 Sep 2009
StemCells, Inc. to Initiate First Ever Neural Stem Cell Trial in Myelination Disorder
Regenerative Medicine Neurology
 HSMN NewsFeed - 3 Sep 2009
Steven Holtzman Joins Satori Pharmaceuticals' Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 31 Aug 2009
Integra NeuroSciences Features New MAYFIELD(R) Infinity XR2 Radiolucent Cranial Stabilization System At World Congress of Neurological Surgery
Devices Neurosurgery
 HSMN NewsFeed - 24 Aug 2009
BrainStorm Cell Therapeutics Secures Funding to Reach Clinical Trials for ALS
Regenerative Medicine Neurology
 HSMN NewsFeed - 24 Aug 2009
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Aug 2009
Stemedica Requests Pre-IND Meeting With FDA
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 7 Aug 2009
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 5 Aug 2009
Ceregene Receives Additional Grant From Michael J. Fox Foundation to Expand Long-Term Testing of CERE-120 Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jul 2009
Pfizer And Medivation Initiate Phase 3 Trial Of Dimebon In Patients With Huntington Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Jul 2009
Raptor Pharmaceuticals Corp. and TorreyPines Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Jun 2009
BioSante Pharmaceuticals and Cell Genesys Sign Definitive Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Jun 2009
William Aliski Named FoldRx Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2009
Power3 Medical Announces Scientific Breakthrough for Its NuroPro(R) Blood Test; Diagnosis of Different Forms of Alzheimer's
Diagnostics Neurology
 HSMN NewsFeed - 20 May 2009
Genzyme and Isis Announce that Mipomersen Phase 3 Study in Patients with Homozygous Familial Hypercholesterolemia Met Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 18 May 2009
Power3 Medical Announces Better Than Expected Results for Early Stage Diagnosis Capability of the NuroPro(R) PD Test for Parkinson's Disease
Diagnostics Neurology
 HSMN NewsFeed - 18 May 2009
Biovail Announces Acquisition of Worldwide Rights to Tetrabenazine
Biopharmaceuticals Neurology Acquisitions
 HSMN NewsFeed - 13 May 2009
Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 May 2009
Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimer's and Parkinson's Diseases at AAN Annual Meeting
Diagnostics Neurology
 HSMN NewsFeed - 7 May 2009
Merck Serono Initiates SETTLE, the Second Phase III Clinical Trial of Safinamide in Advanced Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 May 2009
Merck Serono Launches Glucophage Powder in First European Countries
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 21 Apr 2009
Merck Serono Launches Kuvan(R) in Europe
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2009
Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 13 Apr 2009
Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2009
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 23 Mar 2009
Merck Serono Launches Strategic Venture Capital Fund
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 18 Mar 2009
Power3 Medical 'On-Track and On-Plan' to Commercialize Diagnostic Blood Tests
Diagnostics Neurology
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Genzyme's Synvisc-One for Osteoarthritis of the Knee
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Jan 2009
Merck Serono's Oral Investigational Treatment Cladribine Tablets for Multiple Sclerosis Significantly Reduced Relapse Rate in Two-Year Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Jan 2009
Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Biopharmaceuticals Neurology Venture Capital Personnel
 HSMN NewsFeed - 18 Dec 2008
StemCells, Inc. Receives FDA Approval To Initiate Clinical Trial Of HuCNS-SC® Cells In A Myelin Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 9 Dec 2008
Merck Serono's Kuvan(R) Receives Marketing Authorization in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Nov 2008
Accera, Inc. Completes $35 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Oct 2008
EMD Serono and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
Biopharmaceuticals Licensing
 HSMN NewsFeed - 1 Oct 2008
Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimer's Disease Compound
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Sep 2008
Link Medicine Completes $40 million Series C Financing to Accelerate Development of First Disease-Modifying Treatments for Neurodegenerative Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Sep 2008
Merck Serono's Kuvan(R) Recommended for European Approval
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Sep 2008
Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 12 Sep 2008
Power3 Medical Products, Inc. Appoints Helen Park as Interim Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Sep 2008
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 Sep 2008
World Renowned ALS Expert From Harvard Medical School and Mass. General Hospital, Dr. Robert H. Brown Jr., Joins BrainStorm Cell Therapeutics Scientific Advisory Board
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Aug 2008
Proteostasis Therapeutics Secures a $45 Million Series A Financing to Develop Proteostasis Regulator(TM) Drugs
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Aug 2008
XENAZINE(R) (Tetrabenazine) Approved by FDA for Patients with Chorea Associated with Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Aug 2008
Panacea Pharmaceuticals Announces Appointment of Suzanne Sensabaugh as Vice President, Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jul 2008
Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jul 2008
Insmed Provides Update on IPLEX(TM) Programs
Biopharmaceuticals
 HSMN NewsFeed - 1 Jul 2008
Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
Avid Appoints Richard A. Baron as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jun 2008
Neuro-Hitech, Inc. Announces Acquisition of MCR American Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Jun 2008
Merck Serono Strengthens its Prescription Medicines Portfolio in Latin America
Biopharmaceuticals Distribution
 HSMN NewsFeed - 10 Jun 2008
Merck Serono's Rebif(R) Celebrates 10th Anniversary
BIopharmaceuticals Neurology
 HSMN NewsFeed - 9 Jun 2008
Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntington's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Jun 2008
Merck Serono Announces Initiation of Second Phase II/III Clinical Study of Atacicept in Lupus
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Loic Maurel Joins Exonhit Therapeutics to Become CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 May 2008
Bristol-Myers Squibb to Acquire Kosan Biosciences
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 May 2008
StemCells Confirms Previously Reported Batten Trial Death Was Due to Natural Progression of Disease
Regenerative Medicine Nurology
 HSMN NewsFeed - 19 May 2008
Cortex Pharmaceuticals Announces Management Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 5 May 2008
Unique Three-Year Data Demonstrating Long-Term Efficacy and Safety of Raptiva(R) in the Treatment of Psoriasis Published in the British Journal of Dermatology
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2008
Ceregene Announces Two Key Additions to Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2008
Power3 Medical Products Issues Letter to Shareholders
Diagnostics
 HSMN NewsFeed - 16 Apr 2008
Merck Announces Planned Investment of $50 Million in Research Center in the US
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
Vasogen Announces Implementation of Strategic Restructuring Plan
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2008
Stem Cells From Menstrual Blood Show Therapeutic Potential
Regenerative Medicine
 HSMN NewsFeed - 11 Apr 2008
Status of the E2007 (perampanel) Development Program - Termination of Parkinson's Disease Clinical Development and Focus on Neuropathic Pain and Epilepsy Indications
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2008
Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 19 Mar 2008
Merck Serono Launches Cyanokit(R) in Japan
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Cortex Receives Approval from German Regulatory Authority to Proceed with Two Clinical Trials for AMPAKINE(R) CX717 for the Acute Treatment of Respiratory Depression Due to Opiate Analgesics
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 3 Mar 2008
Vasogen Provides Update on ACCLAIM II Program
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Mar 2008
Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2008
Integra LifeSciences Introduces Titanium Skull Pins for Intra-Operative Brain Surgery
Devices Neurosurgery
 HSMN NewsFeed - 18 Feb 2008
Solvay Pharmaceuticals, Inc. Receives Fast Track Designation From U.S. Food and Drug Administration for Levodopa/Carbidopa Intestinal Gel for Advanced Parkinson's Disease
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 15 Feb 2008
Q Therapeutics Announces Series B Investment
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Feb 2008
QuantRx(R) Biomedical Announces Second Agreement With ALT BioScience to Develop Diagnostic Tests for Oral Health
Diagnostics
 HSMN NewsFeed - 1 Feb 2008
Neuro-Hitech Reports Cognitive Improvement From Phase Two Clinical Trial of Huperzine A In Alzheimer's Disease Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Jan 2008
Molecular Biometrics Hires Denny Sakkas, PhD Renowned Yale Embryologist and International Thought-Leader, as Chief Scientific Officer; Opening U.S. Research Facility
Diagnostics Personnel
 HSMN NewsFeed - 22 Jan 2008
Knopp Neurosciences Completes First Series B Financing of $10 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jan 2008
StemCells, Inc. Provides Batten's Clinical Trial Update
Regenerative Medicine Neurology
 HSMN NewsFeed - 17 Dec 2007
CytRx Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Dec 2007
Ceregene Promotes Dr. Raymond Bartus to Executive Vice President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2007
Amarin Signs Agreement to Acquire Ester Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 3 Dec 2007
StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy, LLC
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 30 Nov 2007
First Patient Completes StemCells, Inc.'s Phase I Clinical Trial
Regenerative Medicine Neurology
 HSMN NewsFeed - 20 Nov 2007
Neuralstem Obtains UCSD Stem Cell Delivery System for Use in Spinal Cord Trials
Regenerative Medicine Neurology Licensing
 HSMN NewsFeed - 12 Nov 2007
BrainStorm Cell Therapeutics Secures Significant Equity Financing and Raises Research Budget
Regenerative Medicine Neurology
 HSMN NewsFeed - 25 Oct 2007
New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Oct 2007
AngioChem Announces IND Clearance From the US FDA for its Lead Product, ANG1005, for the Treatment of Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Oct 2007
Cortex Names Pierre V. Tran, MD, MMM, Chief Medical Officer and Vice President of Clinical Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 15 Oct 2007
Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 12 Oct 2007
Elekta: Finding Hope for Autism - New Brain Research Technology Centre Opened by HRH Princess Anne
Devices Neurology
 HSMN NewsFeed - 12 Oct 2007
Rami Efrati, Former VP Business Development and Marketing for NICE SYSTEMS' Government Division, Joins BrainStorm As CEO
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 10 Oct 2007
Accera, Inc. Names William T. Poncy Vice President of Commercial Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Oct 2007
BrainStorm on the Verge of a Breakthrough Towards Developing a Cure for Lou Gehrig's Disease
Regenerative Medicine Neurology
 HSMN NewsFeed - 3 Oct 2007
Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 26 Sep 2007
EnVivo Pharmaceuticals Announces Executive Appointment
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 178

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 178 additional stories matching:
neurodegenerative
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.